ContextVision, in strategic alliance with NeuSoft Medical Technologies, is planning to launch MAMMO PlusViewCAD, a treatment decision support tool that assists radiologist to more easily detect early stage breast cancers during routine mammography screenings.
CAD (Computer Aided Decision) systems are software specifically developed to examine the digital mammogram images of the breast and screen them for shadings and patterns (that may be indicative of cancer) but that may be extremely difficult to detect with an eye examination alone.
The CAD program examines the x-ray film and highlights areas of the breast, where it detects suspicious patterns (abnormal areas of density, mass, or calcifications) and thus alerts the radiologist to areas in need for further analysis.
Early studies indicate that the use of CAD support systems allowed for an increase in detection of breast cancers in asymptomatic women by up to 20%.
ContextVision is an independent developer in medical imaging enhancement, analysis and processing technologies, serving leading OEMs and distributors.
ContextVision’s patented GOP algorithm allows image quality to be achieved by simultaneously enhancing structure while reducing noise and speckle across MRI, X-Ray, Ultrasound and CT image data.